Article
Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study.
Respiratory research - 27 May 2022
Tan Xueyun, Li Yuan, Wang Sufei, Xia Hui, Meng Rui, Xu Juanjuan, Duan Yanran, Li Yan, Yang Guanghai, Ma Yanling, Jin Yang
Abstract excerpt
BACKGROUND: Timely identification of epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement status in patients with non-small cell lung cancer (NSCLC) is essential for tyrosine kinase inhibitors (TKIs) administration. We aimed to use artificial intelligence (AI) models to predict EGFR mutations and ALK rearrangement status using common demographic features, pathology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
